Metropolis Healthcare Limited (METROPOLIS) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Metropolis Healthcare Limited stock ₹725, price ₹574, upside +26.3%, quality 70 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Metropolis Healthcare Limited
METROPOLIS · NSESolid company and rising price, but only slightly cheap (21% below fair value): meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range ₹296.31 – ₹853.86 · fair‑value band ₹522.22 – ₹906.44 · the ₹574.15 price screens below the ₹725.18 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Metropolis Healthcare is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally.
Show moreShow less
The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinical trial research, hospital lab management, and home collection services, as well as profiles, blood tests, and soft radiology services.
It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, youth, and corporates. In addition, the company develops and deals in technology driven products and services.
The company serves a range of customers, including direct-to-consumer diagnostics through patient service centers, a mobile app, a website, and home collection; partnerships with standalone labs, hospital chains, and diagnostic networks; and institutional clients, such as corporates, government bodies, and hospital lab management services.
Metropolis Healthcare Limited was founded in 1980 and is headquartered in Mumbai, India.
Stock analysis
Metropolis Healthcare Limited (METROPOLIS) currently trades at ₹574.15, while our model-based Fair Value estimate is ₹725.18, implying the stock looks roughly 21% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹240.81 per share, and 0 of the 26 models we run sit above the ₹574.15 price.
Bear case: the Economic Profit group reads lowest at ₹77.96, and 26 of the 26 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹522.22 (bear) to ₹906.44 (bull), the price of ₹574.15 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 70/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Metropolis Healthcare Limited reported revenue of ₹16.5B in FY2026 versus ₹12.3B in FY2022, a compound +7.6%/yr. Reported net income was ₹1.9B in FY2026, compounding −2.9%/yr from FY2022.
Key figures
Market cap ₹119B (≈ $1.3B) Small · P/E ratio 52.3 · P/S ratio 6.66 · EPS (TTM) ₹10.97 · Dividend yield 0.3% · Net margin 12.6% · Return on equity 14.6% · Return on assets (EBIT) 28.6% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 63 out of 100 (low confidence).
What moves the price
The share trades about 5% below its 52-week high and 36% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −9% fair-value upside, at 26%, METROPOLIS screens cheaper than that median.
Fair Value models
All 26 models by family
The fair value above starts from this blend and is adjusted for a year distorted by one-off effects.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch METROPOLIS, get fair value alerts →
Compare Metropolis Healthcare Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 151 stocks
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Quality Score by industry
- Return on equity by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Illumina, Inc ILMN | $198.00 | $227.71 | +15% | vs METROPOLIS |
| WuXi AppTec Co 603259 | ¥144.41 | ¥164.66 | +14% | vs METROPOLIS |
| IQVIA Holdings IQV | $264.73 | $291.63 | +10% | vs METROPOLIS |
| Thermo Fisher Scientific Inc TMO | $691.33 | $686.04 | −1% | vs METROPOLIS |
| Danaher Corporation DHR | $229.91 | $209.18 | −9% | vs METROPOLIS |
| IDEXX Laboratories, Inc IDXX | $700.65 | $496.48 | −29% | vs METROPOLIS |
| Lonza Group LONN | CHF 670.20 | CHF 259.80 | −61% | vs METROPOLIS |
| Mettler-Toledo International Inc MTD | $1,727 | $655.06 | −62% | vs METROPOLIS |
| Agilent Technologies, Inc A | $172.92 | $64.20 | −63% | vs METROPOLIS |
| Waters Corporation WAT | $453.42 | $91.26 | −80% | vs METROPOLIS |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Metropolis Healthcare Limited (METROPOLIS) overvalued or undervalued?
What is the fair value of METROPOLIS?
What is the quality score of METROPOLIS?
What is the price target for Metropolis Healthcare Limited (METROPOLIS)?
What is the Metropolis Healthcare Limited stock forecast for 2026?
What is the revenue of Metropolis Healthcare Limited (METROPOLIS)?
Does Metropolis Healthcare Limited pay a dividend?
How much is the dividend of Metropolis Healthcare Limited (METROPOLIS) and when is the ex-dividend date?
What growth is priced into Metropolis Healthcare Limited (METROPOLIS)?
What discount rate (WACC) does the fair value of METROPOLIS use?
What is a reverse DCF?
How much growth has Metropolis Healthcare Limited (METROPOLIS) delivered so far?
How fast is the sector of Metropolis Healthcare Limited (METROPOLIS) growing?
What is the free cash flow yield of Metropolis Healthcare Limited (METROPOLIS)?
What is the intrinsic value of Metropolis Healthcare Limited (METROPOLIS)?
Is Metropolis Healthcare Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of METROPOLIS?
How much is Metropolis Healthcare Limited worth?
What do the bullish and bearish scenarios say about METROPOLIS?
What is the P/E ratio of METROPOLIS?
How solid is the balance sheet of Metropolis Healthcare Limited (METROPOLIS)?
How far is METROPOLIS from its 52-week high?
Which stocks are comparable to Metropolis Healthcare Limited?
Is Metropolis Healthcare Limited stock attractive at the current price?
How is the fair value of METROPOLIS calculated?
Is it still worth investing in stocks now?
What is the share price of Metropolis Healthcare Limited (METROPOLIS)?
What should I pay attention to with Metropolis Healthcare Limited right now?
Where does the earnings growth of Metropolis Healthcare Limited (METROPOLIS) come from?
Key figures of Metropolis Healthcare Limited
How large is the market capitalisation of Metropolis Healthcare Limited (METROPOLIS)?
What is the P/S ratio of Metropolis Healthcare Limited (METROPOLIS)?
What are the earnings per share of Metropolis Healthcare Limited (METROPOLIS)?
What is the dividend yield of Metropolis Healthcare Limited (METROPOLIS)?
What is the net margin of Metropolis Healthcare Limited (METROPOLIS)?
What is the return on equity of Metropolis Healthcare Limited (METROPOLIS)?
What is the EBIT return on assets of Metropolis Healthcare Limited (METROPOLIS)?
What is the operating margin of Metropolis Healthcare Limited (METROPOLIS)?
How fast is revenue growing at Metropolis Healthcare Limited (METROPOLIS)?
How fast are earnings growing at Metropolis Healthcare Limited (METROPOLIS)?
How much net debt does Metropolis Healthcare Limited (METROPOLIS) carry?
Watch Metropolis Healthcare Limited in the live analysis
One click puts Metropolis Healthcare Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.